Unit Outline

CSA322 is designed to build upon your existing knowledge of pharmacology, physiology, microbiology and evidence-based health, in order to develop the clinical knowledge and skills necessary to deliver pharmaceutical care. Topics include the pathophysiology and therapeutic principles relevant to the management of common diseases. In CSA322, these include cardiovascular, haematological, renal, endocrine and respiratory conditions. An emphasis is placed on the application of knowledge to evaluate and advise upon pharmacotherapy in clinical situations. Although CSA322 and CSA306 (Therapeutics in Practice 3B) are separate units, the learning derived from one is complementary to the other. CSA322 carries a weighting of 25% (i.e. 25 credit points).

Intended Learning Outcomes

As per the Assessment and Results Policy 1.3, your results will reflect your achievement against specified learning outcomes.

On completion of this unit, you will be able to:


1.	Apply an understanding of pathophysiology and epidemiology to the pharmacotherapeutic management (including self-care) of diseases and illnesses of local, national and international importance.
2.	Apply professional problem solving skills to identify critical issues, conceptualise problems, use relevant information and formulate a range of solutions in relation to the provision of medicines or health advice.
3.	Apply an evidence-based decision framework in the management of medicines and the use of healthcare interventions

Requisites


REQUISITE TYPE	REQUISITES
Pre-requisite	(CBA221 AND (CSA207 OR CJA214) AND CSA230 AND CSA231 AND CSA255 AND CSA204 AND CSA225 AND CSA288) OR (CSA119 AND CSA207 AND CSA208 AND CSA209 AND CSA231)
Co-requisite	CSA355

Alterations as a result of student feedback

Several changes have been made to CSA322 for 2024 including but not limited to:

Increased workshop time to allow for in depth discussion on topics taught

Workshop quizzes moved into formative quizzes that can be completed in the students own time to allow students to monitor their progress.

How will I be Assessed?

For more detailed assessment information please see MyLO.

Assessment schedule


ASSESSMENT TASK #	ASSESSMENT TASK NAME	DATE DUE	WEIGHT	LINKS TO INTENDED LEARNING OUTCOMES
Assessment Task 1:	In-workshop oral assessments	Week 2	15 %	LO1, LO2, LO3
Assessment Task 2:	Mid-semester written test	Week 7	20 %	LO1, LO2, LO3
Assessment Task 3:	End of semester oral exam	Exam Period	25 %	LO1, LO2, LO3
Assessment Task 4:	Written exam	Exam Period	40 %	LO1, LO2, LO3

Assessment details

Assessment Task 1: In-workshop oral assessments

Task Description:

During workshops you will complete in workshop oral assessments. The top 3 marks from these attempts will count towards this assessment task.

Task Length: 10 minutes (including feedback)
Due Date - from Week 2

Task Length:

10 minutes

Due Date:

Week 2

Weight:

15 %

CRITERION #

CRITERION

MEASURES INTENDED

LEARNING OUTCOME(S)


1	Apply knowledge and understanding of therapeutic principles, epidemiology and pathophysiology of disease states covered prior to the workshop	LO1, LO2, LO3
2	Display an understanding of medications used in specific diseases, their adverse effects and the patient cohorts they are suitable for.	LO1, LO2, LO3
3	Apply problem-solving skills and evidence based therapeutic knowledge to specific cases.	LO1, LO2, LO3

Assessment Task 2: Mid-semester written test

Task Description:

You will be required to sit a face to face mid-semester test, comprising multiple choice questions (MCQs) and short-answer/case-based questions

Task Length:

50 minutes

Due Date:

Week 7

Weight:

20 %

CRITERION #

CRITERION

MEASURES INTENDED

LEARNING OUTCOME(S)


1	Apply knowledge and understanding of therapeutic principles, epidemiology and pathophysiology of disease states covered prior to the mid-semester test.	LO1, LO2, LO3
2	Display an understanding of medications used in specific diseases, their adverse effects and the patient cohorts they are suitable for.	LO1, LO2, LO3
3	Apply problem-solving skills and evidence based therapeutic knowledge to specific cases.	LO1, LO2, LO3

Assessment Task 3: End of semester oral exam

Task Description:

You will be required to complete an end of semester oral exam, comprising verbalised questions testing your ability to verbally communicate and apply appropriate therapeutic principles in a conversational setting.

Task Length:

15 minutes + 3 minutes reading time

Due Date:

Exam Period

Weight:

25 %

CRITERION #

CRITERION

MEASURES INTENDED

LEARNING OUTCOME(S)


1	Apply knowledge and understanding of therapeutic principles, epidemiology and pathophysiology of disease states covered prior to the exam.	LO1, LO2, LO3
2	Display an understanding of medications used in specific diseases, their adverse effects, and the patient cohorts they are suitable for.	LO1, LO2, LO3
3	Apply problem-solving skills and evidence based therapeutic knowledge to specific cases.	LO1, LO2, LO3

Assessment Task 4: Written exam

Task Description:

You will be required to complete a face to face exam comprising, multiple choice questions (MCQs) and short-answer/case-based questions

Task Length:

2 hour

Due Date:

Exam Period

Weight:

40 %

CRITERION #

CRITERION

MEASURES INTENDED

LEARNING OUTCOME(S)


1	Apply knowledge and understanding of therapeutic principles, epidemiology and pathophysiology of disease states covered prior to the exam.	LO1, LO2, LO3
2	Display an understanding of medications used in specific diseases, their adverse effects and the patient cohorts they are suitable for.	LO1, LO2, LO3
3	Apply problem-solving skills and evidence based therapeutic knowledge to specific cases.	LO1, LO2, LO3

How your final result is determined

To pass this unit, you need to demonstrate your attainment of each of the Intended Learning Outcomes.

Your grade will be determined in the following way:

Once all assessments for CSA322 have been completed, students will be allocated either an Interim Completion (IC) or Assessment Outstanding (AO) grade by the Student Centre.

Students will, however, be informed of their actual mark for CSA322 (via the MyLO grades function). This mark is derived from the four assessment tasks in the unit, weighted as described above.

On completion of CSA306 in Semester 2, an overall mark and grade for 3rd Year Therapeutics in Practice will be derived from the marks for CSA322 and CSA306.

This overall mark will be weighted two-thirds for CSA322 and one-third for CSA306, reflecting the credit points allocated to these two units, i.e., 25 CP and 12.5 CP, respectively. This overall mark and the associated grade will then be applied to both units, over-writing the IC or AO grade originally allocated for CSA322. The Student Centre will communicate this mark and grade to students in the usual way.
An overall mark of at least 50% and a mark of at least 50% in the final CSA306 written exam is required for satisfactory completion of 3rd Year Therapeutics in Practice.

Students who do not meet these two requirements for satisfactory completion of 3rd Year Therapeutics in Practice, but who are eligible for a supplementary exam, will be offered a supplementary exam covering material from both CSA322 and CSA306.

Submission of assignments

Where practicable, assignments should be submitted to an assignment submission folder in MYLO. You must submit assignments by the due date or receive a penalty (unless an extension of time has been approved by the Unit Coordinator). Students submitting any assignment in hard copy, or because of a practicum finalisation, must attach a student cover sheet and signed declaration for the submission to be accepted for marking.

Requests for extensions

If you are unable to submit an assessment task by the due date, you should apply for an extension.

A request for an extension should first be discussed with your Unit Coordinator or teaching support team where possible. A request for an extension must be submitted by the assessment due date, except where you can provide evidence it was not possible to do so. Typically, an application for an extension will be supported by documentary evidence: however, where it is not possible for you to provide evidence please contact your Unit Coordinator.

The Unit Coordinator must notify you of the outcome of an extension request within 3 working days of receiving the request.

Late penalties

Assignments submitted after the deadline will receive a late penalty of 5% of the original available mark for each calendar day (or part day) that the assignment is late. Late submissions will not be accepted more than 10 calendar days after the due date, or after assignments have been returned to other students on a scheduled date, whichever occurs first. Further information on Late Penalties can be found on the Assessments and Results Procedure.

Review of results and appeals

You are entitled to ask for a review of the marking and grading of your assessment task if there is an irregularity in the marking standards or an error in the process for determining the outcome of an assessment. Details on how to request a review of a mark for an assignment are outlined in the Review and Appeal of Academic Decisions Procedure.

Required Resources

Required reading materials

Any required readings will be provided by your Unit Coordinator.